REGENXBIO to Participate in Upcoming Investor Conferences
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Morgan Stanley 21st Annual...
Stay updated with breaking news from Chat Time. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Morgan Stanley 21st Annual...
NORWOOD, Mass., July 31, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. , a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will...
BOSTON--(BUSINESS WIRE)--Jul 26, 2023--
FinancialContent fully hosted finance channel
WESTLAKE VILLAGE, Calif., June 06, 2023 -- Arcutis Biotherapeutics, Inc. , an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced... | June 10, 2023